Failure to Implement Scabies Infection Control Measures
Summary
The facility failed to implement effective infection prevention and control measures for scabies, a highly contagious skin condition, as per their policy and procedure titled 'Scabies Identification, Treatment and Environmental Cleaning.' This deficiency was identified during a recertification survey and involved four residents who were sampled. The facility did not identify and detect symptoms of scabies in a timely manner for a resident who had a skin rash upon readmission. The resident was not placed on contact precautions when treatment with Elimite and Ivermectin began, and the diagnosis of scabies was confirmed days later. The facility also failed to maintain contact precautions as per the physician's order, which was issued after the scabies diagnosis. The resident was not isolated from roommates, and contact precautions were not implemented promptly, increasing the risk of transmission to other residents, staff, and visitors. The infection preventionist acknowledged that contact isolation precautions were initiated late and should have been in place when scabies was suspected. The deficiency resulted in a potential risk of scabies transmission to 86 in-house residents, staff, and the community. The facility's failure to adhere to its scabies policy and procedure led to an Immediate Jeopardy situation, as identified by surveyors, due to the threat posed to the health and safety of residents, staff, and family members.
Removal Plan
- Licensed Nurses completed skin assessments for Residents 1, 2, 3, and 4.
- Resident 1: Noted to have a generalized body rash secondary to diagnosis of eczematous dermatitis and will be re-assessed by a dermatologist after final treatment.
- Resident 2: Noted to have body rash on chest, abdomen, arms, back and thighs secondary to dermatitis.
- Resident 3: Noted to have a body rash on bilateral arm secondary to dermatitis.
- Resident 4: Noted to have body rash extending from back to abdomen secondary to dermatitis.
- Treatment Plan for Residents 1, 2, 3 and 4 included:
- Resident 1: Clobetasol Propionate External Cream 0.05% to generalize body topically daily, Permethrin External Cream 5% to neck and toes topically at bedtime every Thursday and Ivermectin 9 mg via GT every Wednesday.
- Resident 2: Refused treatment and was educated regarding risks of refusing treatment and the importance of receiving treatment. Resident 2 was subsequently placed in contact isolation pending test results.
- Resident 3: Clobetasol Propionate External Cream 0.05% to arms twice daily.
- Resident 4: Hydrocortisone Cream 0.1% and Clindamycin Phosphate External Gel I% to abdomen and back.
- Residents 2, 3, and 4 had skin scraping completed, pending results.
- Environmental Service completed a deep cleaning of the room for Residents 1, 2, 3, and housekeeping department will continue with deep clean schedule for all resident care areas. Work areas were also deep cleaned.
- The Infection Control committee, including the Medical Director held an ad hoc QAA meeting to review the IJ Removal Plan for further review and recommendations.
- The Infection Control Nurse and/or designee connected with the Public Health Nurse for further recommendations and validation to confirm that the facility took all necessary steps for Residents 1, 2, 3, and 4.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release May 27, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



